EV/EBITDA
0.37
0.000.00%
Sat, 08 Feb 2025 00:31:11 GMT
Summary
- As of February 8, 2025, XLO EV/EBITDA is 0.37, unchanged from the previous trading day.
- Over the past year, XLO EV/EBITDA has increased by +0.18 (+94.74%).
- XLO EV/EBITDA is now -70.87% below its all-time high of 1.27.
Performance
XLO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
XLO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | -1.9% | -1.5% |
| 1 m1 month | +164.3% | -176.8% | -33.7% |
| 3 m3 months | +1333.3% | -1212.0% | -46.4% |
| 6 m6 months | -15.9% | +17.6% | -22.3% |
| ytdytd | +105.6% | -111.1% | -29.5% |
| 1 y1 year | +94.7% | -58.0% | +6.3% |
| 5 y5 years | - | - | - |
XLO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | 0.01 | +3600.0% | |
| 3 m | 3-month | 0.37 | at high | -0.12 | +408.3% |
| 6 m | 6-month | 0.52 | -28.9% | -0.15 | +346.7% |
| 1 y | 1-year | 0.52 | -28.9% | -0.37 | +200.0% |
| 3 y | 3-year | 1.27 | -70.9% | -3.02 | +112.3% |
| 5 y | 5-year | 1.27 | -70.9% | -8.17 | +104.5% |
| alltime | all time | 1.27 | -70.9% | -8.17 | +104.5% |
Xilio Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.37(+105.6%) |
| 2024 | 0.18(-14.3%) |
| Date | Value |
|---|---|
| 2023 | 0.21(-32.3%) |
| 2022 | 0.31(-108.8%) |
| 2021 | -3.54 |
FAQ
- What is Xilio Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Xilio Therapeutics?
- What is XLO EV/EBITDA year-to-date change?
- What is Xilio Therapeutics EV/EBITDA year-on-year change?
What is Xilio Therapeutics EV/EBITDA?
The current EV/EBITDA of XLO is 0.37
What is the all time high EV/EBITDA for Xilio Therapeutics?
Xilio Therapeutics all-time high EV/EBITDA is 1.27
What is XLO EV/EBITDA year-to-date change?
Xilio Therapeutics EV/EBITDA has changed by +0.19 (+105.56%) since the beginning of the year
What is Xilio Therapeutics EV/EBITDA year-on-year change?
Over the past year, XLO EV/EBITDA has changed by +0.18 (+94.74%)